Thus, promoter hypermethylation of one or more of the genes p14ARF, RASSF1A and APC1A, when defined by Pyrosequencing assays, might serve as a marker of poor prognosis which we suggest as a novel, relevant stratification factor in future prospective and interventional studies on CRC. This evidence concerns the gene RASSF1 and colorectal carcinoma.